1. 毕业设计（论文）的内容和要求
1．文献查阅掌握文献查阅的一般方法，学会使用计算机在中国期刊网，维普数据库，超星数字图书馆，Elsevier、NCBI电子期刊，Springer Link全文电子期刊，pubmed， Web Of Science等检索资源上查阅关于抗血栓药物机理及纳米递药体系构建的相关文献。
2．文献阅读及综述阅读与课题相关的外文及中文文献，了解国内外的相关研究动态，撰写文献综述。
3．明确实验任务，拟定实验方案根据所查阅文献的内容，确定实验内容及方案，拟定科学可行的研究计划。
2. 参考文献
[1] Kishore S P, Blank E, Heller D J, et al. Modernizing the World Health Organization list of essential medicines for preventing and controlling cardiovascular diseases[J]. Journal of the American College of Cardiology, 2018,71(5):564-574. [2] 国家心血管病中心. 中国心血管病报告2017[G]. 北京: 中国大百科全书出版社, 2017. [3] Wang X, Gkanatsas Y, Palasubramaniam J, et al. Thrombus-targeted theranostic microbubbles: a new technology towards concurrent rapid ultrasound diagnosis and bleeding-free fibrinolytic treatment of thrombosis[J]. Theranostics, 2016,6(5):726. [4] Jackson S P. Arterial thrombosisinsidious, unpredictable and deadly[J]. Nature Medicine, 2011,17(11):1423. [5] Vardanyan R, Hruby V. Synthesis of best-seller drugs[M]. Academic Press, 2016. [6] Di Minno A, Spadarella G, Prisco D, et al. Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: clinical translation and areas of research[J]. Blood Reviews, 2015,29(5):335-343. [7] Peer D, Karp J M, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy[J]. Nature Nanotechnology, 2007,2(12):751. [8] Godin B, Sakamoto J H, Serda R E, et al. Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases[J]. Trends in Pharmacological Sciences, 2010,31(5):199-205. [9] Yu X, Trase I, Ren M, et al. Design of nanoparticle-based carriers for targeted drug delivery[J]. Journal of Nanomaterials, 2016,2016:1-15. [10] Matoba T, Koga J, Nakano K, et al. Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease[J]. Journal of Cardiology, 2017,70(3):206-211. [11] Wei Z, Xin G, Wang H, et al. The diosgenin prodrug nanoparticles with pH-responsive as a drug delivery system uniquely prevents thrombosis without increased bleeding risk[J]. Nanomedicine: Nanotechnology, Biology and Medicine, 2018,14(3):673-684. [12] Zhang N, Li C, Zhou D, et al. Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis[J]. Acta Biomaterialia, 2018,70:227-236. [13] Palekar R U, Myerson J W, Schlesinger P H, et al. Thrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis[J]. Molecular Pharmaceutics, 2013,10(11):4168-4175. [14] Yu M, Jie X, Xu L, et al. Recent advances in dendrimer research for cardiovascular diseases[J]. Biomacromolecules, 2015,16(9):2588-2598. [15] Zhu K, Lai H, Guo C, et al. Novel vascular endothelial growth factor gene delivery system-manipulated mesenchymal stem cells repair infarcted myocardium[J]. Experimental Biology and Medicine, 2012,237(6):678-687. [16] Huo D, Liu G, Li Y, et al. Construction of Antithrombotic Tissue-Engineered Blood Vessel via Reduced Graphene Oxide Based Dual-Enzyme Biomimetic Cascade[J]. ACS Nano, 2017,11(11):10964-10973. [17] Qiao H, Wang Y, Zhang R, et al. MRI/optical dual-modality imaging of vulnerable atherosclerotic plaque with an osteopontin-targeted probe based on Fe3O4 nanoparticles[J]. Biomaterials, 2017,112:336-345. [18] Meier S, P U Tz G, Massing U, et al. Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis[J]. Biomaterials, 2015,53:137-148. [19] Song Y, Huang Z, Xu J, et al. Multimodal SPION-CREKA peptide based agents for molecular imaging of microthrombus in a rat myocardial ischemia-reperfusion model[J]. Biomaterials, 2014,35(9):2961-2970. [20] Xu J, Zhou J, Zhong Y, et al. Phase transition nanoparticles as multimodality contrast agents for the detection of thrombi and for targeting thrombolysis: in vitro and in vivo experiments[J]. ACS Applied Materials mer I, Merrifield R C, et al. Stability of citrate, PVP, and PEG coated silver nanoparticles in ecotoxicology media[J]. Environmental Science Technology, 2012,46(13):7011-7017.[32] Verma V C, Kharwar R N, Gange A C. Biosynthesis of antimicrobial silver nanoparticles by the endophytic fungus Aspergillus clavatus[J]. Nanomedicine, 2010,5(1):33-40.[33] Mahdieh M, Zolanvari A, Azimee A S. Green biosynthesis of silver nanoparticles by Spirulina platensis[J]. Scientia Iranica, 2012,19(3):926-929.[34] Abdeen S, Geo S, Sukanya S, et al. Biosynthesis of silver nanoparticles from Actinomycetes for therapeutic applications[J]. International Journal of Nano Dimension, 2014,5(2):155-162.[35] Shankar S S, Ahmad A, Sastry M. Geranium leaf assisted biosynthesis of silver nanoparticles[J]. Biotechnology Progress, 2003,19(6):1627-1631.[36] Huang J, Li Q, Sun D, et al. Biosynthesis of silver and gold nanoparticles by novel sundried Cinnamomum camphora leaf[J]. Nanotechnology, 2007,18(10):105104.[37] Zhang Y, Cheng X, Zhang Y, et al. Biosynthesis of silver nanoparticles at room temperature using aqueous aloe leaf extract and antibacterial properties[J]. Colloids and Surfaces a: Physicochemical and Engineering Aspects,52013,423:63-68.[38] Austin L A, Mackey M A, Dreaden E C, et al. The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery[J]. Archives of Toxicology, 2014,88(7):1391-1417.[39] Yuan Y, Zhang J, Zhang H, et al. Silver nanoparticle based label-free colorimetric immunosensor for rapid detection of neurogenin 1[J]. Analyst, 2012,137(2):496-501.[40] Fern A Ndez-L O Pez C, Mateo-Mateo C, Alvarez-Puebla R O N A, et al. Highly controlled silica coating of PEG-capped metal nanoparticles and preparation of SERS-encoded particles[J]. Langmuir, 2009,25(24):13894-13899.[41] Austin L A, Kang B, Yen C, et al. Nuclear targeted silver nanospheres perturb the cancer cell cycle differently than those of nanogold[J]. Bioconjugate Chemistry, 2011,22(11):2324-2331.[42] Lobatto M E, Fuster V, Fayad Z A, et al. Perspectives and opportunities for nanomedicine in the management of atherosclerosis[J]. Nature Reviews Drug Discovery, 2011,10(11):835.[43] Cyrus T, Abendschein D R, Caruthers S D, et al. MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles[J]. Journal of Cardiovascular Magnetic Resonance, 2006,8(3):535-541.[44] O'Neil C P, van der Vlies A E J, Velluto D, et al. Extracellular matrix binding mixed micelles for drug delivery applications[J]. Journal of Controlled Release, 2009,137(2):146-151.[45] Kelly K A, Allport J R, Tsourkas A, et al. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle[J]. Circulation Research, 2005,96(3):327-336.[46] Ta H T, Li Z, Hagemeyer C E, et al. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast[J]. Biomaterials, 2017,134:31-42.[47] Modery C L, Ravikumar M, Wong T L, et al. Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery[J]. Biomaterials, 2011,32(35):9504-9514.[48] Juenet M, Aid-Launais R, Li B, et al. Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin[J]. Biomaterials, 2018,156:204-216.[49] Li B, Aid-Launais R, Labour M E L, et al. Functionalized polymer microbubbles as new molecular ultrasound contrast agent to target P-selectin in thrombus[J]. Biomaterials, 2019,194:139-150.[50] Freedman J E. Molecular regulation of platelet-dependent thrombosis[J]. Circulation, 2005,112(17):2725-2734.[51] Cui C, Yang Z, Hu X, et al. Organic semiconducting nanoparticles as efficient photoacoustic agents for lightening early thrombus and monitoring thrombolysis in living mice[J]. ACS Nano, 2017,11(3):3298-3310.[52] Pawlowski C L, Li W, Sun M, et al. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis[J]. Biomaterials, 2017,128:94-108.[53] McCarthy J R, Patel P, Botnaru I, et al. Multimodal nanoagents for the detection of intravascular thrombi[J]. Bioconjugate Chemistry, 2009,20(6):1251-1255.[54] Huang G, Zhou Z, Srinivasan R, et al. Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets[J]. Biomaterials, 2008,29(11):1676-1685.[55] Zhang P, Lin H, Qu C, et al. Design, synthesis, and in vitro antiplatelet aggregation activities of ferulic acid derivatives[J]. Journal of Chemistry, 2015,2015.[56] Tang Y, Duan J, Fan X, et al. Effects of aromatic acids on stimulating blood circulation and removing blood stasis[J]. World Science and Technology, 2008,10(4):38-42.[57] Ma Z, Hong Q, Wang Y, et al. Ferulic acid attenuates adhesion molecule expression in gamma-radiated human umbilical vascular endothelial cells[J]. Biological and Pharmaceutical Bulletin, 2010,33(5):752-758.[58] Ma Z, Hong Q, Wang Y, et al. Ferulic acid protects lymphocytes from radiation-predisposed oxidative stress through extracellular regulated kinase[J]. International Journal of Radiation Biology, 2011,87(2):130-140.[59] Sudheer A R, Chandran K, Marimuthu S, et al. Ferulic acid modulates altered lipid profiles and prooxidant/antioxidant status in circulation during nicotine-induced toxicity: a dose-dependent study[J]. Toxicology Mechanisms and Methods, 2005,15(6):375-381.[60] Hong Q, Ma Z, Huang H, et al. Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling[J]. European Journal of Pharmacology, 2016,777:1-8.[61] Zook J M, Long S E, Cleveland D, et al. Measuring silver nanoparticle dissolution in complex biological and environmental matrices using UV--visible absorbance[J]. Analytical and Bioanalytical Chemistry, 2011,401(6):1993.[62] Maschauer S, Haubner R, Kuwert T, et al. 18F-Glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation[J]. Molecular Pharmaceutics, 2013,11(2):505-515.[63] Austin L A, Mackey M A, Dreaden E C, et al. The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery[J]. Archives of Toxicology, 2014,88(7):1391-1417.[64] 国家, 药典, 委员会. 中 国 药 典 (二 部)[J]. 北 京: 中 国 医 药 科 技 出 版 社, 2015.[65] Wang X, Wei C, Liu M, et al. Near-Infrared Triggered Release of uPA from Nanospheres for Localized Hyperthermia-Enhanced Thrombolysis[J]. Advanced Functional Materials, 2017,27(40):1701824.
以上是毕业论文任务书，课题毕业论文、开题报告、外文翻译、程序设计、图纸设计等资料可联系客服协助查找。
